Geode Capital Management’s RayzeBio RYZB Stock Holding History
Bought
Maintained
Sold
Geode Capital Management's RYZB Position: Q1 2024 in Review
Geode Capital Management sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 434,891 shares — an estimated $27M sold.
Geode Capital Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $27M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.
- Geode Capital Management reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
- Geode Capital Management sold 434,891 RayzeBio shares in Q1 2024, an estimated $27M.
- Geode Capital Management first reported a position in RayzeBio in Q3 2023 and held it in 2 quarters.
- Geode Capital Management's RayzeBio position peaked at $27M in Q4 2023.
- 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.